Dr. Pierre Villeneuve

Dr. Pierre Villeneuve
Dr. Pierre Villeneuve
Assistant Professor, Department of Medicine, Div of Hematology, University of Ottawa

613-737-8899 ext. 71284


Dr. Villeneuve obtained his combined MD and PhD degrees from McGill University and completed his residencies in internal medicine and hematology at the University of Toronto. He then pursued a two years clinical and research fellowship in adoptive therapy and autologous stem cell transplantation at the Princess Margaret Hospital in Toronto. He has completed an M.Sc. in Health Economics, Policy and Management at the London School of Economics.

Dr. Villeneuve is an Assistant Professor at the University of Ottawa where he is member of the Ottawa Blood Disease Center and Ottawa Health Research Institute. His clinical focus is with myeloproliferative neoplasms, myelodysplasia and acute leukemia. His research interest lies in the economic value of interventions in hematological malignancies, addressed through three key axes of research that enable an active role in the decision of healthcare resource allocation. For one, he is interested in performing pharmacoeconomic evaluations of therapies in malignant hematology. Second, he has a research focus in economic evaluations alongside clinical trials in malignant hematology. Third, he is interested in analyzing real-world data to provide useful information for provincial funding agencies on the economic value of interventions in hematology.

Dr. Villeneuve is a member of the pan Canadian Oncology Drug Review and serves the Economic Committee and Hematology Disease Site of the Canadian Clinical Trial Group. At the provincial level, he is a professional Committee Member of the Ontario Steering Committee for Cancer Drug Programs, the hematology drug advisory committee and an Clinical Expert Review Committee of Cancer Care Ontario (Ontario Health).

Research interests

  • Pharmacoeconomics
  • Health Economics
  • Myeloproliferative Neoplasms